Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat in allergic conjunctivitis
NCT01289431Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Feb 2011
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mapracorat in allergic conjunctivitis (AC), sponsored by Bausch + Lomb. Started Feb 2011; status: completed.
02
Drugs
mapracorat
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01289431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289431.